arrow
L

Lindsay L. Peterson

Washington University School of Medicine
H指数:27
被引数:3,270

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Survivorship, Version 2.2024 Featured Updates to the NCCN Guidelines

生存率,版本2.2024版NCCN指南特色更新

2024-12-011
OA
Survivorship, Version 1.2023 Featured Updates to the NCCN Guidelines
2023-08-0122
OA
TK IMPACT: Treatment Monitoring of Hormone Receptor Positive (HR+), HER2 Negative (HER2-) Metastatic Breast Cancer (MBC) Patients Receiving CDK 4/6 Inhibitors (CDK4/6i) with DiviTum® Thymidine Kinase 1 Activity
2023-03-011
PRE
Clinical outcomes of patients with HR+HER2-advanced breast cancer with early progression on CDK4/6 inhibitors
2023-03-011
PRE
Survivorship, Version 1.2022 Featured Updates to the NCCN Guidelines

Survivorship,1.2022版更新了NCCN指南

2022-10-0118
OA
Blood tumor mutational burden (bTMB) and blood copy number burden (bCNB) by genome-wide circulating tumor DNA (ctDNA) assessment predict outcome and resistance in hormone-receptor positive (HR+), HER2 negative (HER2-) metastatic breast cancer (MBC) patients (pts) treated with CDK4/6 inhibitor (CDK4/6i)
2022-02-150
PRE
Identifying a metabolite signature that correlates with tumor proliferation in early-stage breast cancer patients treated with CDK4/6 inhibitors from matched plasma and serum samples
2022-02-150
PRE